Identifying the Brain Circuits that Regulate Pain-Induced Sleep Disturbances
Nicole A. Lynch, Roberto De LucaiD, Richard L. SpinieliiD, Enrico Rillosi, Renner C. Thomas, Samuel Sailesh, Nishta Gangeddula, Janayna D. LimaiD, Sathyajit Sai BandaruiD, Elda ArrigoniiD, Rami BursteiniD, Stephen ThankachaniD, Satvinder KauriD
Abstract
Pain therapies that alleviate both pain and sleep disturbances may be the most effective for pain relief, as both chronic pain and sleep loss render the opioidergic system, targeted by opioids, less sensitive and effective for analgesia. Therefore, we first studied the link between sleep disturbances and the activation of nociceptors in two acute pain models. Activation of nociceptors in both acute inflammatory (AIP) and opto-pain models led to sleep loss, decreased sleep spindle density, and increased sleep fragmentation that lasted 3 to 6 hours. This relationship is facilitated by the transmission of nociceptive signals through the spino-parabrachial pathways, converging at the wake-active PBelCGRP (parabrachial nucleus expressing Calcitonin Gene-Related Peptide) neurons, known to gate aversive stimuli. However, it has never been tested whether the targeted blocking of this wake pathway can alleviate pain-induced sleep disturbances without increasing sleepiness. Therefore, we next used selective ablations or optogenetic silencing and identified the key role played by the glutamatergic PBelCGRP in pain-induced sleep disturbances. Inactivating the PBelCGRP neurons by genetic deletion or optogenetic silencing prevented these sleep disturbances in both pain models. Furthermore, to understand the wake pathways underlying the pain-induced sleep disturbances, we silenced the PBelCGRP terminals at four key sites in the substantia innominata of the basal forebrain (SI-BF), the central nucleus of Amygdala (CeA), the bed nucleus of stria terminalis (BNST), or the lateral hypothalamus (LH). Silencing of the SI-BF and CeA also significantly reversed pain-induced sleep loss, specifically through the action on the CGRP and NMDA receptors. This was also confirmed by site-specific blockade of these receptors pharmacologically. Our results highlight the significant potential for selectively targeting the wake pathway to effectively treat pain and sleep disturbances, which will minimize risks associated with traditional analgesics. One sentence summaryParabrachial CGRP neurons regulate awakenings to pain.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cortico-autonomic local arousals and heightened somatosensory arousability during NREM sleep of mice in neuropathic pain
A. Lüthi, R. Cardis, … I. Decosterd·bioRxiv·Jan 4, 2021
- Simultaneous Brain, Brainstem and Spinal Cord pharmacological-fMRI reveals endogenous opioid network interactions mediating attentional analgesia
Valeria Oliva, Ron Hartley-Davies, … Jonathan CW Brooks·eLifePeer-reviewed·Jan 26, 2022
- Regulation of stress-induced sleep fragmentation by preoptic glutamatergic neurons
Jennifer Smith, Adam Honig-Frand, … Shinjae Chung·Current BiologyPeer-reviewed·Dec 13, 2023
- An amygdalo-parabrachial pathway regulates pain perception and chronic pain
Charles Raver, Olivia Uddin, … Asaf Keller·Journal of NeurosciencePeer-reviewed·Mar 26, 2020
- Convergent state-control of endogenous opioid analgesia
Blake A. Kimmey, Lindsay L. Ejoh, … Gregory F. Corder·Journal of PainPeer-reviewed·Mar 1, 2026
- Pain persists in mice lacking both Substance P and CGRPα signaling
Donald Iain MacDonald, Monessha Jayabalan, … Alexander Theodore Chesler·eLifePeer-reviewed·Mar 7, 2025